With the help of the data and tweets given, can you forecast whether the closing price of $nvs will climb or drop at 2015-05-29? Please state either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2015-05-14,0.3,0.3,-0.4,1.2,1.2,-1.0,-1.2,-1.0,-0.8,-0.8,-1.1
2015-05-15,-0.5,0.2,-0.8,-0.1,-0.1,-0.7,-1.0,-0.9,-0.6,-0.6,-0.8
2015-05-18,0.3,0.5,-0.3,0.3,0.3,-0.7,-1.3,-1.2,-0.8,-0.9,-1.0
2015-05-19,0.1,0.5,-0.1,-0.2,-0.2,-0.2,-0.9,-0.9,-0.6,-0.6,-0.7
2015-05-20,-0.3,0.3,-0.4,-0.3,-0.3,0.3,-0.4,-0.6,-0.3,-0.3,-0.3
2015-05-21,-0.3,0.3,-0.5,1.2,1.2,-0.8,-1.3,-1.6,-1.6,-1.5,-1.5
2015-05-22,0.1,0.7,-0.0,-0.9,-0.9,0.1,-0.3,-0.7,-0.7,-0.5,-0.6
2015-05-26,1.3,1.3,-0.0,-2.0,-2.0,1.7,1.6,1.2,1.2,1.4,1.4
2015-05-27,-0.7,0.2,-0.8,1.7,1.7,-0.0,0.0,-0.4,-0.5,-0.3,-0.3
2015-05-28,-0.4,0.1,-0.7,0.7,0.7,-0.6,-0.5,-0.9,-1.1,-0.9,-1.0

2015-05-14: rt AT_USER #asco15 $clvs $azn egfrm t790m late-comer competition #1 -&gt; $nvs egf816:  54.5% orr
2015-05-23: AT_USER AT_USER $nvs cosentyx (secukinumab) label has no mention of any this type of signal: |rt AT_USER $amgn drops brodalumab, il-17 partnership; solidifying $nvs front runner position 4 their il-17
Answer:
With the help of the data and tweets given, can you forecast whether the closing price of $nvs will climb or drop at 2015-05-29? Please state either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2015-05-14,0.3,0.3,-0.4,1.2,1.2,-1.0,-1.2,-1.0,-0.8,-0.8,-1.1
2015-05-15,-0.5,0.2,-0.8,-0.1,-0.1,-0.7,-1.0,-0.9,-0.6,-0.6,-0.8
2015-05-18,0.3,0.5,-0.3,0.3,0.3,-0.7,-1.3,-1.2,-0.8,-0.9,-1.0
2015-05-19,0.1,0.5,-0.1,-0.2,-0.2,-0.2,-0.9,-0.9,-0.6,-0.6,-0.7
2015-05-20,-0.3,0.3,-0.4,-0.3,-0.3,0.3,-0.4,-0.6,-0.3,-0.3,-0.3
2015-05-21,-0.3,0.3,-0.5,1.2,1.2,-0.8,-1.3,-1.6,-1.6,-1.5,-1.5
2015-05-22,0.1,0.7,-0.0,-0.9,-0.9,0.1,-0.3,-0.7,-0.7,-0.5,-0.6
2015-05-26,1.3,1.3,-0.0,-2.0,-2.0,1.7,1.6,1.2,1.2,1.4,1.4
2015-05-27,-0.7,0.2,-0.8,1.7,1.7,-0.0,0.0,-0.4,-0.5,-0.3,-0.3
2015-05-28,-0.4,0.1,-0.7,0.7,0.7,-0.6,-0.5,-0.9,-1.1,-0.9,-1.0

2015-05-14: rt AT_USER #asco15 $clvs $azn egfrm t790m late-comer competition #1 -&gt; $nvs egf816:  54.5% orr
2015-05-23: AT_USER AT_USER $nvs cosentyx (secukinumab) label has no mention of any this type of signal: |rt AT_USER $amgn drops brodalumab, il-17 partnership; solidifying $nvs front runner position 4 their il-17
Answer:+Fall